Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Students at Milwaukee School of Engineering are developing artificial red blood cells as a potential solution to recurrent blood shortages, reports ABC2 News.
President Donald Trump on Wednesday met with the Congressional Black Caucus to discuss ongoing political issues, including high drug costs, reports Politico.
A study, published in JAMA Surgery, examined the link between providing surgeons with individualized cost feedback and surgical supply costs in the operating room.
The Food and Drug Administration awarded tentative approval to Mylan's antiretroviral drug TLE400.
Newron Therapeutics on Thursday earned approval from the Food and Drug Administration for its drug Xadago.
The Food and Drug Administration on Tuesday introduced its Regenerative Medicine Advanced Therapy Designation.
The Food and Drug Administration on Tuesday confirmed a link between breast implants and a rare form of lymphoma.
A majority of Americans over age 50 oppose measures in the House-proposed ACA replacement bill that would drive up healthcare costs for older individuals, according to a recent AARP survey.
The Food and Drug Administration approved more than 99 percent of expanded access requests in 2016, reports Regulatory Focus.
The Food and Drug Administration is warning clinicians that patients implanted with Abbott Laboratories' Absorb dissolving stent may experience more heart issues than those implanted with the company's Xience drug-eluting stent.